Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
While it's great you're focused on the CEO who left 7 years ago and on irrelevant events of the past, perhaps you could comment on a current relevant issue that we shareholders who are not leadership actually care about:
Why has Venturis Therapeutics has not run a single clinical trial since 2007?
For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156705047
You're right, johnnymcgriffin347. Maybe Grant could also spend his time working on the Alcoholic Impotence indication for Venturis's drug. If he doesn't push for that to move forward, it's probably not going to happen because the rumor is Calvin Wallen III is indifferent to it (and as Calvin reportedly said to Grant, "I've already got Calvin Wallen IV, why should I give a damn?"). Perhaps it's too late for the drug to be helpful to Grant (if the rumors about Grant are true), but hopefully he cares about the alcoholics who follow in his wake.
#DrunksDeserveBabiesToo
I believe Grant Gordon is soon going to have a LOT of time on his hands. What's unclear to me is whether or not Venturis Therapeutics will declare bankruptcy to put off Dan Montano's collection efforts now that Montano has won a 7-figure judgment against Venturis/CVBT, or just be liquidated by its creditors. Six of one, half a dozen of the other I guess. Hopefully Grant will use whatever time he has left to work on his presentation delivery skills (cough cough). I'll admit, I was laughing when I saw his presentation, primarily due to his completely inept delivery (the content itself is another reason to laugh, but I was pretty much just laughing at the hostage video....err, I mean Grant).
Does anyone know if Grant was sober during that presentation? He didn't come across as being all there.
For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=157315665
Do you mean the presentation where Grant Gordon looks and sounds as if he's reading someone else's very unfamiliar words, like in a hostage video? And comes across as convincing as even the best of hostages do?
The Bankruptcy of Venturis Therapeutics
Venturis Therapeutics is bankrupt, literally and certainly morally. Having recently suffered a binding non-appealable 7-figure adverse judgment, this insolvent and illiquid company is all but certainly unable to pay it, which I believe will result one way or another in the liquidation of this zombie company. Here is more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156705047
But aside from the literal bankruptcy, the moral bankruptcy is equally significant. Not only is the company controlled and led by someone the U.S. government accuses is a crook--and I'm referring to Calvin Wallen III. But every time a shareholder raises a valid question about the company, not only do we not get a response, but instead the company and its supporters seek to divert the discussion to "Shittya" (the new company of the former CEO) or any extraneous topic that is anything but the question being asked. And that shows how bankrupt Venturis Therapeutics and its people are.
The company refuses to answer two (2) simple questions:
1) Why has Venturis not run a single clinical trial since 2007, in spite of numerous promises otherwise?
2) Why does Venturis refuse to release audited financial statements?
What financial information Venturis apparently does release, according to others on this board, is compiled financial statements from the auditors, hoping no one will notice that those are not audited statements but are rather just management's numbers on the auditor's letterhead. Big difference. Well, according to Robert Schleizer, Venturis CFO, the last audited statements that we know of came with a going concern qualification from the auditors. I guess that's not something the company wants people to see, though. And if there were more recent statements that did not have a going concern qualification from the auditors, something tells me we would have seen them. I wonder why we haven't?
Instead, all we get are bad attempts at diversion, obfuscation, and confusion. No one is fooled. Venturis and its leadership team has zero credibility with anyone--and even each other as rumors have it (a departed insider spilled the beans).
Well, the end is here. It won't be much longer before this company disappears. I already took my tax write-off. But I refuse to remain quiet, and will remain witness to the lies and deceit that are Venturis and its crooked leadership team.
Question 12: Which of these statements was NOT made by one of the members of Venturis Therapeutics’s leadership team at one of the annual shareholders meetings?
(By popular demand, we are re-visiting this subject from Question 11 with new and different quotes. There's a link to Question 11 below if you did not see it the first time.)
A) Calvin Wallen III: "Dr. Meyerson has been published over 100 times, and information on him is available on the Internet. You can see his publications, track record, what he has done in the industry. He is a strong biotech influence on the company."" (2018)
B) Grant Gordon: "Alright, I'm a high school dropout, I can own that. And I'm an alcoholic and have been drinking continually for over 4 decades, it's just the way it is. And maybe I'm not the most reliable person on the planet. But that doesn't mean that when I tell you that Venturis is about to close on a huge sum of equity, or that the clinical trials are about to re-start, or that Calvin Wallen is innocent of the charges filed against him by the U.S. government for allegedly stealing $14 million from his previous company, it doesn't mean I'm not telling the truth. Because if I said it, I believe it to be true. Isn't that enough for all of you? Thank you." (2020)
C) Calvin Wallen III: "We hope to the bring to the marketplace over the next 12 months news of what we are hoping to enjoy." (2016)
D) Jon Ross: "There is one employee being compensated in cash by the company." (2016)
E) Robert Schleizer: "The company had a net loss of $2.8 million in 2017." (2018)
F) Calvin Wallen: "We've been working hard." (2018)
(The correct answer is listed below)
This is part of our new Venturis Therapeutics educational trivia series. Unlike our cheap imitators who lack a single original thought in their minimally-educated brains, ours is an educational and fun exercise for the whole family while we're mostly not social distancing anymore (and are now sorry we didn't).
For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156608105
The correct answer is: (B). This was again easy, for two reasons. One, because Venturis Therapeutics did not hold a shareholders meeting in 2020--in violation of its bylaws and stated promises to shareholders. Two, because since Calvin Wallen's hostile takeover, Grant Gordon has never spoken at a shareholders meeting (Mr. Wallen probably doesn't dare risk it). If you chose any answer other than (B), you really haven't been paying attention.
For fun, let's go through and review each of these choices.
(A) I remember laughing out loud at this statement when Mr. Wallen made it, because in one paragraph it reveals Calvin Wallen's complete buffoonery. Breaking News: Dr. Meyerson's career has been in pharmaceuticals, not biotechnology. But to a dropout like Mr. Wallen who doesn't know a protein from a chemical, what's the difference? And I love that final sentence, "He's a strong biotech influence on the company." Boy is that ever a statement.
(C) This is another Calvin Wallen doozy that had me laughing out loud at the time he made it. File this one under, "A statement that reflects the quality of the mind it came from." If you have any idea what his confused mind was trying to say, please let us all know. Does anyone know if Calvin Wallen III went by the name Nigel Tufnel earlier in life?
(D) Yes, I also loved this Jon Ross statement, in response to a question posed by a shareholder. Mr. Ross's statement reflects the stench of the company...er, I mean strength, that they only were paying one employee in cash. Mr. Ross proved Calvin Wallen's point that if you want to look smarter, surround yourself with dumber people. Also, by some strange coincidence, it's the last time that Mr. Ross ever spoke at a shareholders meeting. I wonder why?
(E) This quote is significant because it's the only time during the Calvin Wallen era we've ever been told any financial information about the company. Of course, in the next sentence Mr. Schleizer also indicated that the company received a going concern qualification from its auditors.
(F) When Mr. Wallen told us in 2018 that "We've been working hard," every shareholder breathed a sigh of relief. Because based on the non-existent results from CVBT/Venturis, we were all wondering if anyone was actually working beyond the one employee being paid in cash. Thankfully Mr. Wallen re-assured us they were.
Maybe this is a good time to review what a high-placed Venturis Therapeutics insider who left the company had to say:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155941891
For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156885999
And here are the earlier questions in our series:
Question 1: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155716885
Question 2: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155768166
Question 3: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155830431
Question 4: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155887684
Question 5: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156041065
Question 6: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156227658
Question 7: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156355920
Question 8: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156535390
Question 9: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156702737
Question 10: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156857356
Question 11: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156983504
The End of Venturis Therapeutics
With Venturis Therapeutics (formerly Cardiovascular Biotherapeutics or CVBT) losing a 7-figure binding arbitration judgment to its former CEO Dan Montano (and one of these days we'll learn the final amount once the judge issues his final ruling), this insolvent, illiquid, and thoroughly broken zombie company has finally reached the end of the road. I believe the doors of this zombie company get shut once and for all fairly soon.
While a 7-figure binding judgment would not necessarily be fatal for a viable company, I believe it is something Venturis (the textbook definition of a zombie company) will not survive for one fundamental reason: Because Venturis is not viable, has not been viable for over a decade, and can not raise the money needed to go forward. Why? Because no one is going to put money into a company where the controlling shareholder/CEO, Calvin Wallen III, is an accused crook who has been accused by the U.S. government of stealing $14 million from his previous company, and who has had credible repeated allegations of falsified books and records at companies he has been associated with. Indeed, I find it telling that Mr. Wallen has taken a scorched earth approach to delay, delay, delay his trial (with an assist from coronavirus). It's been 3 years now that Mr. Wallen has successfully delayed his day of reckoning...er, excuse me, his opportuniy to clear his (ahem) "good name." Let me ask you one question: If you genuinely thought you were innocent and would be exonerated at a trial of (falsely) stealing so much money, wouldn't you want that trial to be held yesterday? I would! I personally believe that the fact Mr. Wallen has done everything possible to delay his trial all but screams to the world, "I'm guilty!"
So let's talk about that case, because it's been a while. Mr. Wallen is accused by the U.S. government of stealing a total of $14 million from his former company, Tauren Exploration Inc., prior to its bankruptcy. This is speculation on my part, but having read a number of the filings in this case, I suspect that when Mr. Wallen knew the company was doomed due to the large drop in gas prices, he started stealing from the company, figuring that in bankruptcy no one would notice the missing sums (and I know I'm not the only one who believes that some of these monies were diverted to CVBT/Venturis). Tauren did file bankruptcy, but someone did notice that something was wrong--a major creditor who notified the bankruptcy trustee. As a result, the bankruptcy trustee hired forensic accountants to investigate, and lo and behold, they discovered a series of cash diversions totaling $14 million to external accounts controlled by Mr. Wallen for which they could find no justifiable business reasons. Further, they also found attempts by Mr. Wallen to cover up those diversions. In one of the filings by the U.S. government, they detail the dates, amounts, and unrelated bank accounts that the money was siphoned off to. That means that unbeknownst to Mr. Wallen, the government subpoenad bank records and accounting records of other entities to understand these transactions. It's all pretty damning, I must say, and it's hard to see how Mr. Wallen can have any sort of defense in the face of a third party independent expert (i.e. the forensic accountants) testifying what they found. Hence, why Mr. Wallen has taken a scorched earth approach to delay, delay, delay. His day of reckoning is coming, and having read the government filings, I don't see any way that he gets exonerated. Further, I spoke with a bankruptcy attorney in TX who is not connected to this case, to get his take on it. After a quick review, he said to me, "The government does not lose cases like this." Time will tell.
So let me ask a question: If you're an investor and otherwise like the Venturis story (except maybe the part where the company has not run a single clinical trial since 2007), and were inclined to invest, would you put a dime into a company where the dude in control is accused by the U.S. government of being a crook?
And thus, that is why Venturis has reached the end of the road. No one will put a dime into this broken zombie company. Mr. Wallen does not have the money, stolen or otherwise, to make Venturis viable, and no one will acquire it because the existing data is no longer usable for regulatory purposes. Venturis CEO Robert Schleizer stated at the shareholders meeting in 2018 that the company received a qualified opinion letter from its auditors, with a going concern qualification. It's over.
If you'd like to read about the various court cases where the U.S. government is pursuing Calvin Wallen and related entities, here are the links:
Tauren Exploration, Inc. Liquidating Trust vs. Calvin Wallen III:
https://www.pacermonitor.com/public/case/24021776/Tauren_Exploration,_Inc_Liquidating_Trust_v_Wallen,_III
Tauren Exploration, Inc. Liquidating Trust vs. Pandale Holdings, Inc. et. al:
https://www.pacermonitor.com/public/case/24021775/Tauren_Exploration,_Inc_Liquidating_Trust_v_Pandale_Holdings,_Inc_et_al
Tauren Exploration, Inc. Liquidating Trust v. Fossil Operating, Inc. et al:
https://www.pacermonitor.com/public/case/24021777/Tauren_Exploration,_Inc_Liquidating_Trust_v_Fossil_Operating_Inc_et_al
And here's a lengthier discussion of why Humpty Dumpty (a.k.a. Venturis Therapeutics) is beyond repair:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155716827
And here's what a Venturis insider revealed about what's really going on at this zombie company:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155941891
News? hahahahaha! That's an infomercial.
I guess that's the best Venturis has got.
This only confirms how dire the situation is at this zombie company.
For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156705047
And make sure to look at this:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156885999
And Question 11 in our quiz series is a really good one:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156983504
Question 11: Which of these statements was NOT made by one of the members of Venturis Therapeutics’s leadership team at one of the annual shareholders meetings?
A) Robert Schleizer: "We will receive a qualified audit as a going concern." (2018)
B) Calvin Wallen III: "Everyone wants to know as much as they can [about Venturis]. We would like to tell everyone as much as we can. But the more we speak to, the more we expose ourselves to other entities pirating our science and our work. There are certain things we are just not allowed to talk about. Therefore we have to hold those things close to ourselves." (2019)
C) Calvin Wallen III: "We anticipate re-opening the clinical trials relatively soon." (2016)
D) Calvin Wallen III: “[One of our achievements is] integrating ourselves in the Dallas biotech community.” (2016)
E) Dr. Laurence Meyerson: “Severe CAD [clinical trial], in Phase IIa, resumes in the first half of 2019.” (2018)
F) Grant Gordon: “It’s incredible what Calvin has done here by drifting the listless ship, iceberg [mumbles], swimming [pause]…FDA better. Thank you.” (2020)
(The correct answer is listed below)
This is part of our new Venturis Therapeutics educational trivia series. Unlike our cheap imitators who lack a single original thought in their minimally-educated brains, ours is an educational and fun exercise for the whole family while we're mostly not social distancing anymore (and are now sorry we didn't).
For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156608105
The correct answer is: (F). This was easy, for two reasons. One, because Venturis Therapeutics did not hold a shareholders meeting in 2020--in violation of its bylaws and stated promises to shareholders. Two, because since Calvin Wallen's hostile takeover, Grant Gordon has never spoken at a shareholders meeting (Mr. Wallen probably doesn't dare risk it). If you chose any answer other than (F), you haven't been paying attention.
For fun, let's go through and review each of these choices.
(A) Yes, Robert Schleizer stated it himself that Venturis received a qualified audit as a going concern. And nothing has changed materially for the better since then.
(B) Calvin Wallen himself has stated at multiple shareholders meetings that CVBT/Venturis was not going to be forthcoming with information about the company, in order to protect itself against hostile parties. And it hasn't been. Yet such "information" allegedly leaks out in "rumors" that are publicly shared (although good news rumors inevitably turn out to be false). Think about that. And review Question 10 in our quiz series if you're unclear what this might mean.
(C) Calvin Wallen has told us on more than one occasion (as have others) that the clinical trials would be resuming "soon." Not one clinical trial has been run since 2007. Mr. Wallen, would you care to define the word "soon" for us?
(D) I love this quote! Calvin Wallen told us what a great achievement it had been for Venturis to have successfully integrated itself into the Dallas biotech community. (There is one?) No further comment is necessary.
(E) Dr. Meyerson gave us a very specific date for the resumption of the Phase IIa trial. Maybe I missed it, but did that trial resume in 2019 as Dr. Meyerson indicated? What about in 2020?
Maybe this is a good time to review what a high-placed Venturis Therapeutics insider who left the company had to say:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155941891
For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156885999
And here are the earlier questions in our series:
Question 1: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155716885
Question 2: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155768166
Question 3: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155830431
Question 4: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155887684
Question 5: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156041065
Question 6: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156227658
Question 7: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156355920
Question 8: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156535390
Question 9: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156702737
Question 10: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156857356
BEWARE (Updated): Someone's apparently trying to dump their Venturis Therapeutics stock onto unsuspecting investors, and given the reference to "GG" it may well be Grant Gordon. Venturis is an insolvent, illiquid, failed company that is facing imminent liquidation after having lost a 7-figure judgement. I believe anyone who purchases stock in this company through a private stock transaction (see posts #2373 and #2445) is going to lose 100% of their investment, and in near-record time.
Further, there is a pattern of "rumors" emering from Venturis which intensify for a period of time (like now), but which are almost always false. Make sure you read this posting from my quiz series, which through humor suggests what's really happening and why:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156857356
Make sure you also read about the company's imminent demise:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156705047
You may also want to read about recent developments:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156636621
A public service message brought to you by Walhall.
Question 10: Of the many false rumors floated over the years regarding Venturis Therapeutics (formerly Cardiovascular Biotherapeutics or CVBT), which one turned out to actually be true?
(For reasons revealed below, you'll learn this is a particularly timely question.)
A. Venturis/CVBT was about to go public again “soon”, after many years of being de-listed.
B. Venturis/CVBT was “imminently” about to close on an 8-figure investment from Asia.
C. The clinical trials would be re-starting “next year”.
D. Some major industry company was looking closely at Venturis and a partnering deal was imminent.
E. A very high profile investor was “about” to make a very large investment in Venturis/CVBT.
F. Venturis Therapeutics was going to lose a 7-figure judgment at the hands of its former CEO.
G. Calvin Wallen’s trial by the U.S. government for allegedly stealing $14 million from his previous company was based on corruption and/or a profound miscarriage of justice, and was imminently about to be settled.
(You will note this is a particularly timely question for our quiz, and the reason why is explained below where the correct answer is revealed.)
This is part of our new Venturis Therapeutics educational trivia series. Unlike our cheap imitators who lack a single original thought in their minimally-educated brains, ours is an educational and fun exercise for the whole family while we're mostly not social distancing anymore (and are now sorry we didn't).
For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156608105
The correct answer is: (F). Yes, while rumors were floating that in the binding arbitration case Dan Montano was going to lose catastrophically, in fact it worked out the other way around. Venturis lost the case, and the plaintiffs were awarded a 7-figure judgment. The exact total dollar amount has not yet been revealed, but we will have it soon. This is a judgment that an insolvent, illiquid company like Venturis is all but certainly unable to pay, and that's why most of us who are not leadership believe that Venturis will soon be liquidated.
However, it's important to take a close look below at the incorrect answers, because there's a pattern which seems to repeat itself over and over again (and we seem to be currently in it). I'm confident you'll figure it out.
(A) - It seems many times over the years the "rumor" has floated out of CVBT/Venturis that the company is about to go public. Around the time of the rumor, Grant Gordon's name pops up and people are directed to speak with him about the major transaction that is about to occur. But the event never occurs.
(B) - Likewise we have heard many times that the company is about to close on a sizeable new investment. The numbers keep changing. All that doesn't change, however, is that it never happens. But around the time of the rumor, Grant Gordon's name pops up and people are directed to speak with him about it. But the event never occurs.
(C) - How mahy times have we heard that the clinical trials will be starting "next year"? Too many times to count. And of course not a single clinical trial has been run since 2007. Around the time of the rumor, Grant Gordon's name pops up and people are directed to speak with him about the clinical trials re-starting again. But the event never occurs.
(D) - And of course there's the old favorite, some major partnering deal is about to be announced with a big pharma partner. But gosh, it has never happened just yet! How come? But around the times of the rumor, Grant Gordon's name pops up and people are directed to speak with him about it. But the event never occurs.
(E) - Ah, yes, the number of times it's been "rumored" that some major new investor was about to take a position in this company. But gosh, that never seems to happen.. Yet around the time of the rumor, Grant Gordon's name pops up and people are directed to speak with him about him, and wouldn't you know it, he often has some clients who need cash and are willing to sell stock now even though great news is coming? But the event never occurs.
(G) - Ah yes, we've heard time and time again that a settlement is near for the U.S. government's case against Venturis CEO Calvin Wallen III, for allegedly stealing $14 million. We're always told it's just a corrupt action from the swamps of Louisiana and it's all going to go away soon. But it never does! Around the time of the rumor, Grant Gordon's name pops up and people are directed to speak with him to discuss the coming great developments. But the event never occurs.
The bottom line: We still seem to be in this same pattern. There are "rumors" floating out of the company that some big event is about to occur. If the past is any sort of guide, we know what will happen - nothing. But curiously, Grant Gordon's name has repeatedly popped up yet again (for example, see posts #2445 and #2373), and people are encouraged to talk to him to find out about things. Now mind you, Venturis does not return calls from shareholders, and the company did not hold its 2020 annual shareholders meeting in violation of its bylaws, but one of the top two executives suddenly makes himself available to talk to people. Hmmmm...something tells me that Grant knows people who need cash and unfortunately have to sell their Venturis stock at this time. Well, take a look at this earlier posting:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156783935
And here are the earlier questions in our series:
Question 1: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155716885
Question 2: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155768166
Question 3: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155830431
Question 4: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155887684
Question 5: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156041065
Question 6: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156227658
Question 7: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156355920
Question 8: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156535390
Question 9: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156702737
Grant Gordon, you know perfectly well that Judge Gary Spraker stated that CVBT/Venturis is unable to pay its debts as they become due. Further, I have already previously posted the link to where one can find this in writing, but in response you and/or others keep saying "prove to me he said it" when I already have. I don't respond to trolls. My postings are all available for anyone to review, so feel free to review them. I promise you, you will find the link. That is, if you want to find the link. But we both know you don't.
You also know that Venturis Therapeutics CFO Robert Schleizer stated at one of the annual meetings that the company received a qualified opinion from its auditors with a going concern qualification. I know he said it, because I recorded it. If you think he did not say it, why don't you ask him yourself? Or better yet, why don't you bring a lawsuit for defamation? We both know you won't do either, because he said this with his own mouth. And it's true as well--which is not guaranteed when dealing with the leadership of this company.
Congratulations to Venturis for getting a multi-billion dollar valuation from CBIZ. For those who do not know who CBIZ is (I didn't), the company's website indicates "CBIZ is one of the nation’s leading providers of professional advisory services, focused on accounting, benefits and insurance, HR and payroll solutions." Boy, that's who I'd want valuing my biotech company! What a joke. It honestly makes me laugh thinking about it. What sort of idiots do you think would read that and think that anything they have to say is even a little credible? You might as well have hired Staples to do the same thing, it probably would have been cheaper (Staples also offers accounting, and HR and payroll solutions). But we both know there's a reason why this valuation is not from who it SHOULD be from: Goldman Sachs, Morgan Stanley, etc., etc. And anyone with a single functioning brain cell will also understand how ridiculous that valuation is. Did you know that Bert's Tax Service down the street also does business valuations?
Would you care to tell us all WHY Venturis Therapeutics has not run a single clinical trial since 2007? You seem unwilling to address this issue, yet it's the single most important one.
Thanks again for the tremendous laugh you gave me today about CBIZ. It made my day.
So here's some more information about the company CBIZ who has allegedly given a multi-billion dollar valuation to Venturis Therapeutics.
From the company's website, front page:
CBIZ is one of the nation’s leading providers of professional advisory services, focused on accounting, benefits and insurance, HR and payroll solutions.
In large font and bold letters the company lists its expertise:
Accounting
Insurance
Advisory
HAHAHAHAHAHAHAAHA!!!!!
I guess that's who I'd want to have value my biotech company credibly, a company that is focused on accounting, benefits and insurance, HR and payroll solutions. This is beyond hysterical!! I literally was laughing so hard when I read this.
Venturis Therapeutics might as well have hired H&R Block to perform its valuation. Heck, at least everyone has heard of them. And they may be more credible in biotech than CBIZ.
It's like wanting to serve a wonderful French meal for dinner guests, and going to McDonalds for recipes.
Thanks to Venturis Therapeutics for starting my weekend with a huge laugh and a gigantic smile on my face. This is incredibly funny.
For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156837193
The bankruptcy of Venturis Therapeutics
1) It's awesome! Faced with facts about the dire situation at Venturis which put to rest that the company is both insolvent and illiquid, its supporters can only deny that bankruptcy judge Gary Spraker said that Venturis is illiquid and CFO Robert Schleizer said that it received a going concern qualification from its auditors. When the best "defense" that can be offered is that these individuals did not say what they PUBLICLY STATED, it's over.
2) CBIZ is the source of this company's valuation? HAHAHHAHAHAHAHA It says everything that Venturis Therapeutics cites a valuation from CBIZ (who???), not Goldman Sachs, Morgan Stanley, Bank of America Merrill Lynch, Jefferies, Cowen, Leerink, etc., whose valuations would be taken seriously. It's self-discrediting.
3) Let's go back to the key fact: VENTURIS THERAPEUTICS HAS NOT RUN A SINGLE CLINICAL TRIAL SINCE 2007. That's 13+ years for those that don't want to do the math. End of story. This is a dead, broken company. Humpty Dumpty can not be put back together again.
4) For those of you who didn't see it, a high-placed insider who left the company in frustration spilled the beans about the company's desperate condition:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155941891
5) Does anyone put money into a company where the CEO is accused by the U.S. government of stealing $14 million from his previous company? Hell no! But that's the situation here. The U.S. government has accused Calvin Wallen III of stealing $14 million from his previous company. Mr. Wallen has successfully delayed his trial for 3 years now (with an assist from coronavirus), but the day of reckoning is coming soon. A TX bankruptcy attorney I spoke with who is not involved with this case but is familiar with its outlines said to me, "the govesrnment does not lose cases like this." But hey, why not read it for yourself?
Tauren Exploration, Inc. Liquidating Trust vs. Calvin Wallen III:
https://www.pacermonitor.com/public/case/24021776/Tauren_Exploration,_Inc_Liquidating_Trust_v_Wallen,_III
Tauren Exploration, Inc. Liquidating Trust vs. Pandale Holdings, Inc. et. al:
https://www.pacermonitor.com/public/case/24021775/Tauren_Exploration,_Inc_Liquidating_Trust_v_Pandale_Holdings,_Inc_et_al
Tauren Exploration, Inc. Liquidating Trust v. Fossil Operating, Inc. et al:
https://www.pacermonitor.com/public/case/24021777/Tauren_Exploration,_Inc_Liquidating_Trust_v_Fossil_Operating_Inc_et_al
Utter nonsense! There are two narratives here, and the question is, whose narrative will anyone believe? The narrative from a U.S. government bankruptcy judge (Judge Gary Spraker) AND the company's CFO (Robert Schleizer), or the narrative of anonymous individuals who say the very opposite of the public record?
Judge Spraker stated in the Cardiovascular Biotherapeutics bankruptcy case that CVBT (which renamed itself Venturis Therapeutics) is unable to pay its debts as they become due. That means the company is illiquid. Venturis CFO Robert Schleizer said at the annual shareholders meeting that the company received a qualified opinion letter from its auditors, with a going concern qualification. That means the company is insolvent.
Venturis supporters can talk all they want about valuations prepared by H&R Block or whatever other ridiculous sources that do valuations of car washes, restaurants, and oh yeah biotech companies too, but as far as anyone reasonable is concerned, if it doesn't come from Goldman Sachs or someone equally reputable in biotech, it's junk. Did this valuation come from Goldman Sachs, Morgan Stanley, Jefferies, Leerink, Cowen, or anyone like that? Of course not.
Venturis Therapeutics is all but worthless. Why do I say that?
FACT: This zombie company has not run a single clinical trial since 2007. Right there, that puts to rest any claims that Venturis is a valuable company. It's not--it's a dead company.
FACT: Venturis just lost a 7-figure judgment that it all but certainly can not pay. And the company was caught lying about it.
FACT: This company is facing a relentless collection effort and is about to be liquidated one way or another.
FACT: The company's CEO is awaiting a trial bought by the U.S. government for allegedly stealing $14 million from his previous company. There are no investors who are going to put a dime into Venturis until this matter is resolved one way or another. Hopefully Calvin Wallen III clears his good name. But that's highly unlikely given the government's overwhelming evidence and case against him. I know, because I've read the documents. And if you haven't but would like to, see the links below.
End of discussion. Have a nice weekend!
For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156705047
If you'd like to learn more about the upcoming trial of Venturis CEO Calvin Wallen III, who is accused by the U.S. government of stealing $14 million from his previous company, here are the links to the court records in these related cases:
Tauren Exploration, Inc. Liquidating Trust vs. Calvin Wallen III:
https://www.pacermonitor.com/public/case/24021776/Tauren_Exploration,_Inc_Liquidating_Trust_v_Wallen,_III
Tauren Exploration, Inc. Liquidating Trust vs. Pandale Holdings, Inc. et. al:
https://www.pacermonitor.com/public/case/24021775/Tauren_Exploration,_Inc_Liquidating_Trust_v_Pandale_Holdings,_Inc_et_al
Tauren Exploration, Inc. Liquidating Trust v. Fossil Operating, Inc. et al:
https://www.pacermonitor.com/public/case/24021777/Tauren_Exploration,_Inc_Liquidating_Trust_v_Fossil_Operating_Inc_et_al
Two Very Significant Venturis Therapeutics Developments
There have been two major news developments at Venturis Therapeutics in recent weeks (formerly Cardiovascular Biotherapeutics or CVBT), but as these are so important (and so telling) it would be a good idea for everyone to take a close look at the details here because they matter so much.
1) Venturis caught in another lie: Venturis Therapeutics was AGAIN caught red-handed trying to cover up bad news. This is a pattern with the dishonest leadership team of Calvin Wallen III and Grant Gordon, where Venturis says something publicly and it subsequently blows up on them, and then they try to pretend it was never said in the first place. Unfortunately Venturis’s mindset about covering things up is pre-Internet when search engines didn’t exist. But what would you expect from dishonest uneducated dropouts, who between the two of them have only one high school diploma and no college or advanced degrees? But ooops...you won't find those facts in their bios.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156561987
2) An Insider Tells All: A Venturis Therapeutics insider who left the company spoke to someone I know who is also a shareholder, and he/she spilled the beans on what’s really going on at Venturis / CVBT. Be sure to read this:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155941891
The bottom line: This zombie company has suffered a catastrophic 7-figure loss in a binding arbitration case that it now pretends did not happen, and that it can not pay. Once the final dollar figure is declared by the judge sometime later this month (July 2020), an aggressive collection effort is likely to commence. I believe it will result in either the liquidation of Venturis Therapeutics or a bankruptcy filing that results in the same. All roads lead to liquidation and the end of Venturis Therapeutics, and soon.
For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156705047
I'm far more interested in Venturis Therapeutics' plans for its (non-existent) clinical trials. Did you know that Venturis has not run a single clinical trial since 2007? I suspect not. But I'm happy to keep reminding stakeholders of this critical fact. It would seem to me this should be a lot more concerning to Venturis shareholders than frankly anything else.
Why is it that the company has nothing to say about clinical trials? Isn't that supposed to be the whole point of a development-stage biotech company?
But I believe none of this matters, as Venturis is all but certainly going to be liquidated, and very soon:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156705047
Understanding Venturis Therapeutic's AI Pathway, Part 2
I think the AI indication (Alcoholic Impotence) for Venturis Therapeutics's drug is one of the most important opportunities the company has. Why? Because look at the valuations on Wall Street. They are valuing companies at incredible premiums that are developing treatments in significant disease areas where there are none, or represent a major breakthrough over standard of care. This is potentially both.
Dr. Angus Innes has published a validated algorithm that is used to screen AI (Alcoholic Impotent) patients, and I believe this algorithm has significant implications for Venturis Therapeutics, as it will greatly assist in screening/recruiting patients for the company's clinical trials (assuming Venturis doesn't get liquidated soon, which is likely to happen). Dr. Innes's algorithm is a scoring system that takes the number of years the alcoholic has been drinking at an alcoholic level (1-70), multiplied by the number of blackouts the alcoholic experiences each year (1-200), multiplied by the number of months each year the alcoholic drinks at all (1-12). If the score is less than 150, there is hope. But if the score exceeds 150, statistical and regression analysis indicates the alcoholic is never going to have children on his own. The only hope for such an alcoholic is if someone develops a therapeutic intervention.
So let's test the algorithm. It's well known that one of the members of Venturis Therapeutics's leadership team suffers from AI and has been unable to bear any children even with multiple wives. Let's apply Dr. Innes's algorithm to his circumstances to see what it indicates.
A) Number of years the alcoholic has been drinking at an alcoholic level: Well, this individual turns 58 in 2020, and he's reportedly been drinking at an alcoholic level since his early teens (and probably earlier). So it's safe to say the number here is 45.
B) The number of blackouts the alcoholic experiences each year: Rumor has it that this alcoholic is good for at least one blackout per week. So it's safe to say the number here is 52.
C) The number of months per year the alcoholic drinks: This one is easy: 12.
Analysis of the results: According to Dr. Innes, to reach the screening score, we would multiple 45 x 52 x 12. That equals 28,080. Now let's compare this to Dr. Innes's findings. Dr. Innes indicates that any score over 150 indicates alcoholic impotence. My goodness..this score is so far over that threshhold. Does it set a record? Only Dr. Innes can tell us that.
The bottom line: I believe that Venturis Therapeutics has found Patient #1 for its AI clinical trial.
If you did not see it, here is Part 1 of this series:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156636596
And if you'd like to understand why Venturis Therapeutics is on the verge of liquidation, take a look at this:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156705047
Coming soon: Part 3
BEWARE: Someone is apparently trying to dump their Venturis Therapeutics stock onto unsuspecting investors, and given the reference to "GG" it may well be Grant Gordon. Venturis is an insolvent, illiquid, failed company that is facing imminent liquidation after having lost a 7-figure judgement. I believe anyone who purchases stock in this company through a private stock transaction (see post #2373) is going to lose 100% of their investment, and in near-record time.
Make sure you read about the company's imminent demise:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156705047
Make sure you read about recent developments:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156636621
A public service message brought to you by Walhall.
Yes, it's exciting that Venturis will be announcing more useless patents! Hopefully there's an AI patent (Alcoholic Impotence) in the mix.
Will this announcement come before the 7-figure collection effort and the resulting liquidation of Venturis Therapeutics begins?
For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156705047
Does anyone know how many shares of Venturis Therapeutics stock Calvin Wallen III and Grant Gordon have given to themselves in the last few years, while:
- Not one single clinical trial has taken place
- Not one investor has announced investment in this company
- There's been a revolving door of medical/scientific leaders
One would think that with the dismal record of results that Calvin Wallen and Grant Gordon have produced at Venturis Therapeutics (which used to be called Cardiovascular Biotherapeutics or CVBT), rather than granting stock to themselves for a job terribly done, they'd instead not have been so greedy and dishonest (in my opinion). Oh well, that's like asking a zebra to lose its stripes.
I suppose it doesn't matter in the end since Venturis Therapeutics is about to be liquidated, but still, it bothers those of us who are shareholders who put hard, real cash into this sucker.
For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156705047
And here are some recent developments:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156709434
Keeping Recent Venturis Therapeutics News Front/Central
There have been two major news developments at Venturis Therapeutics in recent weeks (formerly Cardiovascular Biotherapeutics or CVBT), but I’m going to draw attention to them today (and keep them in front of everyone regularly) because they are so important.
1) Venturis caught in another lie: Venturis Therapeutics was AGAIN caught red-handed trying to cover up bad news. This is a pattern with the dishonest leadership team of Calvin Wallen III and Grant Gordon, where Venturis says something publicly and it subsequently blows up on them, and then they try to pretend it was never said in the first place. Unfortunately Venturis’s mindset about covering things up is pre-Internet when search engines didn’t exist. But what would you expect from dishonest uneducated dropouts, who between the two of them have only one high school diploma and no college or advanced degrees? But ooops...you won't find those facts in their bios.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156561987
2) An Insider Tells All: A Venturis Therapeutics insider who left the company spoke to someone I know who is also a shareholder, and he/she spilled the beans on what’s really going on at Venturis / CVBT. Be sure to read this:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155941891
The bottom line: This zombie company has suffered a catastrophic 7-figure loss in a binding arbitration case that it now pretends did not happen, and that it can not pay. Once the final dollar figure is declared by the judge sometime later this month (July 2020), an aggressive collection effort is likely to commence. I believe it will result in either the liquidation of Venturis Therapeutics or a bankruptcy filing that results in the same. All roads lead to liquidation and the end of Venturis Therapeutics, and soon.
For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156705047
How zombie companies like Venturis Therapeutics die (Updated)
Venturis Therapeutics (formerly Cardiovascular Biotherapeutics or CVBT) has for all practical purposes been dead since 2008. But like a good zombie company, it has continued onwards pointlessly for another 13 years, trying to give every impression of viability where there is none. Zzzombie….zzzombie….zzzzzzombie…….zzzzzzzzzzzzz.........
But even zombie companies like Venturis Therapeutics eventually die. And that death for Venturis is at hand, now that Venturis has suffered a crushing 7-figure judgment it reportedly can’t pay. The final judgment amount will be issued by the judge sometime in July 2020. Worse than that, Venturis was caught red-handed trying to hide this fact, by first posting a press release on its website defiantly declaring a non-existent victory after the judge's decision was issued, and then quietly removing it recently when it became apparent someone must have been drunk and disconnected from reality when they wrote that. Further, Venturis is facing a winning adversary that is rumored to be planning very aggressive collection efforts. Once the final judgment amount is announced by the judge arbitrator, the collection effort is likely to immediately commence.
The only question unclear to me is whether or not Venturis’s death will come from involuntary bankruptcy and liquidation, or if Venturis will file for bankruptcy itself in the onslaught of collection activities and then be liquidated (there is no revenue stream here, so liquidation is certain). One fact is clear to me: Venturis will not be able to pay the judgment. The company has been insolvent for over a decade, and according to a particular insider who left the company and spoke candidly with a shareholder who reached out to him/her, Venturis/CVBT has been out of cash for years (i.e. illiquid) and is unable to advance on anything meaningful or costly (patents are cheap, and in this case, pointless). All the absurd chatter here indicating that Venturis Therapeutics or CVBT has raised $10 million, $150 million, $2 billion, or whatever fictional number suits the moment, based on valuations that exceed Apple’s or whatever nonsense is being spouted, is pure fantasy with a strong alcoholic delusional component. Let's face it, no one is going to invest a dime in a company that's led by an accused crook who's alleged by the U.S. governement to have stolen $14 million from his previous company, and who has repeated accusations of fraud hovering around companies he's been involved with, more than a few of which have ended up in bankruptcy. I'm referring of course to Calvin Wallen III. Venturis has provided zero evidence that any money has come in—-because it didn’t as best anyone can tell. Indeed, CFO Robert Schleizer said at one of the annual shareholder meetings that the company had received a qualified audit from its auditors with a going concern disclaimer. Do you know what that’s called in accounting circles? The death spiral. Companies rarely recover from it. And this one won’t.
So long, farewell, auf wiedersehen, goodbye...
For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155716827
And to hear more from a Venturis insider who spilled the beans:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155941891
And for those of you who would like to learn more about the upcoming trial of Venturis CEO Calvin Wallen III, who is accused by the U.S. government of stealing $14 million from his previous company, here are the links to the court records in these related cases:
Tauren Exploration, Inc. Liquidating Trust vs. Calvin Wallen III:
https://www.pacermonitor.com/public/case/24021776/Tauren_Exploration,_Inc_Liquidating_Trust_v_Wallen,_III
Tauren Exploration, Inc. Liquidating Trust vs. Pandale Holdings, Inc. et. al:
https://www.pacermonitor.com/public/case/24021775/Tauren_Exploration,_Inc_Liquidating_Trust_v_Pandale_Holdings,_Inc_et_al
Tauren Exploration, Inc. Liquidating Trust v. Fossil Operating, Inc. et al:
https://www.pacermonitor.com/public/case/24021777/Tauren_Exploration,_Inc_Liquidating_Trust_v_Fossil_Operating_Inc_et_al
"I must admit, I am stupid AND uneducated..."
So you're saying you're part of Venturis Therapeutics' leadership team? Just seeking clarification.
Question 9: How much money is Venturis Therapeutics Chairman and CEO Calvin Wallen III accused by the U.S. government of stealing from his previous company, Tauren Exploration?
A) $14 million
B) $24 million
C) $34 million
D) $46 million
E) Over $50 million
(The correct answer is at the bottom of this posting)
This is part of our new Venturis Therapeutics educational trivia series. Unlike our cheap imitators who lack a single original thought in their minimally-educated brains, ours is an educational and fun exercise for the whole family while we're mostly not social distancing anymore (and are now sorry we didn't).
For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156608105
The correct answer is: (A), Calvin Wallen III is accused by the U.S. government of stealing $14 million from his previous company, Tauren Exploration Inc. He has successfully delayed his trial for nearly 3 years now (with an assist to the coronavirus), taking a scorched-earth approach to delay, delay, delay. This is of course the sign of a man who believes he is innocent and whose alleged "good name" will be cleared at the trial. However, it's clear from reading the court documents that the government has him nailed, as forensic accounts have discovered the dates, times and bank accounts in which the alleged stolen money was diverted for no legitimate business reasons. It's all detailed in a court filing for anyone who would like to see the evidence. In the words of a TX bankruptcy attorney who is not connected with this case but is familiar with its outlines, "the government does not lose cases like this." I believe that once Mr. Wallen is found guilty in this civil trial, the matter will automaticaly be referred for criminal prosecution (which is a matter of law because of the size of the theft). In addition, I believe the IRS will get involved, because if the money was in fact stolen by Mr. Wallen, the next question will be, did he pay taxes on it? If he did, then he has nothing to be concerned about it. And if he didn't, well, I think the IRS will be more than happy to go the Al Capone route on him. Oh, and by the way, the multiple anonymous comments indicating that the matter has gone to arbitration are categorically false and an obvious attempt to obfuscate the matter. What HAS gone to arbitration is another delaying attempt by Mr. Wallen, to get court confirmation of the amount he is alleged to have stolen. That confirmation is inevitable. And once that happens (or it may have happened already), it will clear the way for Mr. Wallen's trial. The bankruptcy attorney in TX indicated that in his experience the government does not settle cases like this, unless Mr. Wallen plans to plead guilty. Time will tell...
If you're interested, here are the links to the court records in these related cases:
Tauren Exploration, Inc. Liquidating Trust vs. Calvin Wallen III:
https://www.pacermonitor.com/public/case/24021776/Tauren_Exploration,_Inc_Liquidating_Trust_v_Wallen,_III
Tauren Exploration, Inc. Liquidating Trust vs. Pandale Holdings, Inc. et. al:
https://www.pacermonitor.com/public/case/24021775/Tauren_Exploration,_Inc_Liquidating_Trust_v_Pandale_Holdings,_Inc_et_al
Tauren Exploration, Inc. Liquidating Trust v. Fossil Operating, Inc. et al:
https://www.pacermonitor.com/public/case/24021777/Tauren_Exploration,_Inc_Liquidating_Trust_v_Fossil_Operating_Inc_et_al
And here are the earlier questions in our series:
Question 1: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155716885
Question 2: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155768166
Question 3: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155830431
Question 4: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155887684
Question 5: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156041065
Question 6: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156227658
Question 7: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156355920
Question 8: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156535390
The Tragedy of Venturis Therapeutics, Part 2
I'm glad that the Guinness Book of World Records is looking closely at Venturis Therapeutics (formerly Cardiovascular Biotherapeutics or CVBT). While Venturis clearly breaks a new world record--the first biotech company in history to be run (into the ground) by dropouts who don't even have a single college degree amongst the top leaders, Venturis is also a candidate for having the stupidest leadership team of a biotech company ever. Maybe they even qualify for a third world record too--the most dishonest leadership team as well.
And Venturis Therapeutics refuses to answer legitimate questions. Whenever any shareholder asks questions about the lack of any clinical trials since 2007, the many broken promises and lies, etc., the annual shareholders meeting in 2020 which never happened when it was required to according to the company's bylaws, all we hear back from leadership are the following non-sequitors:
"Dan Montano!"
"Shittya!"
"Patents!" (what a joke - racking up useless patents accomplishes nothing)
"Valuation!" (which is the biggest joke of all--this company is worthless, just watch how little it produces in liquidation)
Yes, Venturis is soon to be enshrined on the ash heap of history. And these buffoons who call themselves leaders--Calvin Wallen III, Grant Gordon (who is aided and abetted by Amy Montano Gordon, who doesn't get any sort of pass here, as she is as complicit and responsible for this colossal failure as the rest of them), Mickael Flaa (a.k.a. Mike Flaa), Corey Flaa...all of them are a bunch of failures. It's that simple.
For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156608105
The Tragedy of Venturis Therapeutics
I'm writing the epitaph of this company because its liquidation is a certainty at this point and right around the corner. But as I think about the situation, one of the great tragedies of Venturis (formerly Cardiovascular Biotherapeutics or CVBT) is how it was destroyed by really stupid people: Calvin Wallen III, Grant Gordon, and yes, Grant Gordon's wife Amy Montano Gordon, who was an employee of this company for a number of years and an active participant in its downfall. I'm not saying they're stupid because none of them are educated--that's obvious. Education is no guarantee of intelligence--I know plenty of educated people who are stupid as well. But these three are uneducated AND stupid.
None of this had to happen. I've harped on the fact that all of these people are dropouts, that among Calvin and Grant there is exactly one high school diploma and no college or advanced degrees. It's been my experience in life that stupid people hang out with other stupid people, because let's face it, intelligent people are not going to spend time with idiots, and stupid people don't like hanging around smart people because it makes them feel inadequate in fundamental ways. It's no secret that substance abuse issues loom large among some in the leadership of Venturis. Still, I think the core issue is not substance abuse, but rather that we're just dealing with really stupid people who are so far in over their heads that they're clueless. Think Trump and coronavirus as a comparator.
When shareholders pose reasonable questions that any shareholder deserves answers to, like:
- Why hasn't this company run a single clinical trial since 2007?
- Why didn't the new investors and new money that Calvin Wallen promised would come into the company with him materialize?
- Why all the broken promises and outright lies?
etc. etc.
...we get no actual answers. Just an attempt to change the subject, obviously and stupidly. In my opinion, this company's leadership doesn't have an honest bone in any of their bodies, let alone any intelligent ones.
The epitaph for Venturis Therapeutics, formerly known as Cardiovascular Biotherapeutics, is this:
Venturis is what happens when idiots who think they are intelligent play biotechnology.
The end.
For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156608105
Major Venturis Therapeutics News – DO NOT OVERLOOK, Updated
There have been two (2) really significant news developments at Venturis Therapeutics (formerly Cardiovascular Biotherapeutics or CVBT) that have been noted on this board, but I’m going to draw attention to them today (and keep them in front of everyone regularly) because they are so important.
1) Venturis Therapeutics was AGAIN caught red-handed trying to cover up bad news. This is a pattern with the dishonest leadership team of Calvin Wallen III and Grant Gordon, where Venturis says something publicly and it subsequently blows up on them, and then they try to pretend it was never said in the first place. Unfortunately Venturis’s mindset about covering things up is pre-Internet when search engines didn’t exist. But what would you expect from dishonest uneducated dropouts, who between the two of them have only one high school diploma and no college or advanced degrees? But ooops...you won't find those facts in their bios.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156561987
2) A Venturis Therapeutics insider who left the company spoke to someone I know who is also a shareholder, and he/she spilled the beans on what’s really going on at Venturis / CVBT. Be sure to read this:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155941891
The bottom line: This zombie company has suffered a catastrophic 7-figure loss in a binding arbitration case that it now pretends did not happen, and that it can not pay. Once the final dollar figure is declared by the judge, an aggressive collection effort is likely to commence. I believe it will result in either the liquidation of Venturis Therapeutics or a bankruptcy filing that results in the same. All roads lead to liquidation and the end of Venturis Therapeutics, and soon.
For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156608105
Understanding Venturis Therapeutics’s AI pathway, Part 1
I’ve been doing lots of research on Venturis Therapeutics’s potential for an AI indication (alcoholic impotence). The more I learn, the more it’s clear to me there’s a tremendous opportunity.
One of the best sources for information on alcoholic impotence is Dr. Emil Schaffhausen, an M.D. and epidemiological historian who founded Klinik Zurich. Dr. Schaffhausen stresses in his writings that he believes AI is a genetic disease. His research indicates AI travels genetically in families especially, communities, and even specific countries. To this point research has been unable to identify the specific genes involved, but that’s more due to a lack of funding than anything else.
Donning his epidemiological historian mask, Dr. Schaffhausen believes he has pinpointed ground zero for AI: Glasgow, Scotland. Scotland has a higher prevalence of AI than anywhere in the world, concentrated in Glasgow and across the west coast.
According to the AI Foundation, symptoms of AI (beyond the obvious) are irrational possessiveness towards others’ children, creating reasons to attack friends and colleagues who have many children (due to misfocused anger), and in many cases a descent into autoalcoholism and alcoholic dementia (formerly called alcoholic madness).
We need to have sympathy for alcoholics suffering from AI. It’s not easy for them to see normal people around them having so many beautiful babies, as this reminds them of their continuing failures.
While eliminating alcohol consumption might theoretically help, another AI researcher, Dr. Angus Innes, believes that once the disease has progressed beyond a certain point, the odds of ever having a baby all but vanish. Dr. Innes published a validated formula after years of crunching big data to accurately measure AI. It’s a scoring system that takes the number of years the alcoholic has been drinking at an alcoholic level (1-70), multiplied by the number of blackouts the alcoholic experiences each year (1-200), multiplied by the number of months each year the alcoholic drinks at all (1-12). If the score is less than 150, there is hope. But if the score exceeds 150, statistical and regression analysis indicates the alcoholic is never going to have children on his own. The only hope for such an alcoholic is if someone develops a therapeutic intervention.
There’s reason to believe Venturis Therapeutics could be that someone. Alcoholics should have the right to have children just like normal people do. They shouldn’t be laughed at and ridiculed like AI patients are. They need Venturis Therapeutics’s support.
Given the consistent lies and broken promises from the leadership of Venturis Therapeutics (formerly Cardiovascular Biotherapeutics or CVBT), in the coming weeks we will have a series reviewing some of these. While I'll leave it to the U.S. government, who is already pursuing Calvin Wallen III for allegedly stealing $14 million from his previous company and for fraud and bankruptcy fraud, in my opinion there's a lot of fraud from Calvin Wallen and Grant Gordon related to the hostile takeover of CVBT as well that should have been pursued.
I believe that Mr. Wallen is eventually headed to prison once the U.S. government finishes what they're doing, and the fact remains that Mr. Wallen has indirectly confirmed this by his scorched-earth efforts to delay, delay, delay, delay, delay his trial. For nearly 3 years now (although he's not resposible for the coronavirus delays). Why would anyone want to delay their day in court if they believe they're actually innocent and want to clear their (cough cough) good name? Speaking for myself, if I were falsely accused of some terrible crime and I was innocent, I'd want that trial to take place as quickly as possible, and the last thing I'd be doing is finding every reason possible to delay it. In my opinion, Mr. Wallen's delaying tactics are all but an admission of guilt (that, plus the evidence against him - the U.S. government has the dates, amounts, and bank account information for all the money he allegedly stole and where he sent it, which forensic auditors uncovered).
Regardless, the good news is Calvin Wallen III's day of reckoning is coming, and once it does, I'm assured by a bankruptcy attorney in TX who is not involved in this case but is familiar with its outlines, that "the government doesn't lose cases like this."
And by the way, anyone who thinks that Venturis Therapeutics is salvagable or has a valuation greater than zero (because this company is actually worthless) should read these court documents for one particular reason: BECAUSE NO ONE REMOTELY INTELLIGENT PUTS MONEY INTO A COMPANY WHERE THE LEADERSHIP IS ACCUSED BY THE U.S. GOVERNMENT OF BEING CROOKS. Venturis is dead, dead, dead, and even over the Internet one can smell its carcass.
Here are links to the U.S. government's related cases against Calvin Wallen III:
Tauren Exploration, Inc. Liquidating Trust vs. Calvin Wallen III:
https://www.pacermonitor.com/public/case/24021776/Tauren_Exploration,_Inc_Liquidating_Trust_v_Wallen,_III
Tauren Exploration, Inc. Liquidating Trust vs. Pandale Holdings, Inc. et. al:
https://www.pacermonitor.com/public/case/24021775/Tauren_Exploration,_Inc_Liquidating_Trust_v_Pandale_Holdings,_Inc_et_al
Tauren Exploration, Inc. Liquidating Trust v. Fossil Operating, Inc. et al:
https://www.pacermonitor.com/public/case/24021777/Tauren_Exploration,_Inc_Liquidating_Trust_v_Fossil_Operating_Inc_et_al
How zombie companies like Venturis Therapeutics die (Updated)
Venturis Therapeutics (formerly Cardiovascular Biotherapeutics or CVBT) has for all practical purposes been dead since 2008. But like a good zombie company, it has continued onwards pointlessly for another 13 years, trying to give every impression of viability where there is none. Zzzombie….zzzombie….zzzzzzombie…….zzzzzzzzzzzzz.........
But even zombie companies like Venturis Therapeutics eventually die. And that death for Venturis is at hand, now that Venturis has suffered a crushing 7-figure judgment it reportedly can’t pay. And worse than that, Venturis was caught red-handed trying to hide this fact, by first posting a press release on its website defiantly declaring a non-existent victory after the judge's decision was issued, and then quietly removing it recently when it became apparent someone must have been drunk and disconnected from reality when they wrote that. Further, Venturis is facing a winning adversary that is rumored to be planning very aggressive collection efforts. Once the final judgment amount is announced by the judge arbitrator, the collection effort is likely to immediately commence.
The only question unclear to me is whether or not Venturis’s death will come from involuntary bankruptcy and liquidation, or if Venturis will file for bankruptcy itself in the onslaught of collection activities and then be liquidated (there is no revenue stream here, so liquidation is certain). One fact is clear to me: Venturis will not be able to pay the judgment. The company has been insolvent for over a decade, and according to a particular insider who left the company and spoke candidly with a shareholder who reached out to him/her, Venturis/CVBT has been out of cash for years (i.e. illiquid) and is unable to advance on anything meaningful or costly (patents are cheap, and in this case, pointless). All the absurd chatter here indicating that Venturis Therapeutics or CVBT has raised $10 million, $150 million, $2 billion, or whatever fictional number suits the moment, based on valuations that exceed Apple’s or whatever nonsense is being spouted, is pure fantasy with a strong alcoholic delusional component. Let's face it, no one is going to invest a dime in a company that's led by an accused crook who's alleged by the U.S. governement to have stolen $14 million from his previous company, and who has repeated accusations of fraud hovering around companies he's been involved with, more than a few of which have ended up in bankruptcy. I'm referring of course to Calvin Wallen III. Venturis has provided zero evidence that any money has come in—-because it didn’t as best anyone can tell. Indeed, CFO Robert Schleizer said at one of the annual shareholder meetings that the company had received a qualified audit from its auditors with a going concern disclaimer. Do you know what that’s called in accounting circles? The death spiral. Companies rarely recover from it. And this one won’t.
So long, farewell, auf wiedersehen, goodbye...
For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155716827
And to hear more from a Venturis insider who spilled the beans:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155941891
Major Venturis Therapeutics News – DO NOT OVERLOOK
There have been two (2) really significant news developments at Venturis Therapeutics (formerly Cardiovascular Biotherapeutics or CVBT) that have been noted on this board, but I’m going to draw attention to them today (and keep them in front of everyone regularly) because they are so important.
1) A Venturis Therapeutics insider who left the company spoke to someone I know who is also a shareholder, and he/she spilled the beans on what’s really going on at Venturis / CVBT.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155941891
2) Venturis Therapeutics was AGAIN caught red-handed trying to cover up bad news. This is a pattern with the dishonest leadership team of Calvin Wallen III and Grant Gordon, where Venturis says something publicly and it subsequently blows up on them, and then they try to pretend it was never said in the first place. Unfortunately Venturis’s mindset about covering things up is pre-Internet when search engines didn’t exist. But what would you expect from dishonest uneducated dropouts, who between the two of them have only one high school diploma and no college or advanced degrees? But ooops...you won't find those facts in their bios.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156561987
The bottom line: This zombie company has suffered a catastrophic 7-figure loss in a binding arbitration case that it now pretends did not happen, and that it can not pay. Once the final dollar figure is declared by the judge, an aggressive collection effort is likely to commence. I believe it will result in either the liquidation of Venturis Therapeutics or a bankruptcy filing that results in the same. All roads lead to liquidation and the end of Venturis Therapeutics, and soon.
For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156515237
To quote Ronald Reagan, "there you go again." All that Venturis Therapeutics leadership can talk about is what happened in 2014 when Calvin Wallen III's hostile takeover succeeded. What the company will NEVER talk about is what's happened since then, which is NOTHING. The company has run no clinical trials in 2014, in 2015, in 2016, in 2017, in 2018, in 2019, in 2020....just broken promises and lies. That's what happens when an alleged crook and confirmed dropout, Calvin Wallen III, is running the company (Mr. Wallen has been accused by the U.S. government of stealing $14 million from his previous company and is awaiting trial, which he has been delaying for as long as possible--the sign of someone who truly believes they are innocent and wants to clear their (cough cough) good name).
Why doesn't Venturis Therapeutics want to talk about anything since 2014 and its many and continuing failures?
Here's the answer:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155716827
And to hear more from a Venturis insider who spilled the beans:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155941891
And as a follow on...what anyone interested in Venturis Therapeutics SHOULD ask Grant Gordon about is Alcoholic Impotence and Venturis' AI indication. I understand Grant is the company's expert in Alcoholic Impotence.
BEWARE: Asking Grant Gordon about the valuation of Venturis Therapeutics is like asking Bernie Madoff if he knows of any good investment opportunities.
For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156515237
Research into Venturis Therapeutics's prospective new indication
Coming this week...I've been doing research into Venturis Therapeutics's prospective new indication, and will be sharing my findings over multiple days and postings. I believe that anyone interested in Venturis will find this topic really interesting. Let's just hope that Venturis can make headway here before being liquidated.
Stay tuned...
For more information about Venturis's forthcoming liquidation in the event the company can't pay the 7-figure judgment levied against it:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156515237
Venturis Therapeutics supporters (a.k.a. the leadership team) remind me of Aunt Blabby. She's that crazy relative we all have who won't stop saying ridiculous things while the rest of us listen and knowingly shrug to each other. The good news is we won't have to listen to Aunt Blabby much longer because the liquidation of Venturis Therapeutics is close at hand.
For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156515237
Venturis Therapeutics finally acknowledges CATASTROPHIC ADVERSE JUDGMENT
Well, it finally happened. Venturis Therapeutics finally acknowledged that it suffered a catastrophic adverse judgment in February 2020 in the Dan Montano case. How do we know this? Well, for those of us with good memories, shortly afterwards, Venturis Therapeutics posted a defiant press release on its website that apparently bore little resemblance to the judge's actual ruling (as I've heard through my Venturis Therapeutics sources). If one read the company's press release one would think this was much ado about nothing, not a catastrophic 7-figure adverse judgment the company can not pay. And the echo chamber on here has only amplified that moronic conclusion (or is it an alcoholic one?).
But guess what? Mysteriously as we inch towards a final $,$$$,$$$ determination from the judge (that's 7-figures for those sober enough to count), that press release has magically vanished from Venturis Therapeutics's website. Poof! Just like the press release on October 2, 2018 announcing the new Chief Medical Officer Dr. Ori Ben-Yehuda, who left the company soon thereafter, resulting in the press release suddenly and mysteriously disappearing from the company's website without explanation, turning Dr. Ben-Yehuda overnight into a non-person.
But thanks to the Vecho chamber (the Venturis Therapeutics echo chamber), the Venturis Therapeutics press release touting its "victory" in this lawsuit has been preserved on this message board. I want to thank johnnyblades2001 and SlalomKing, among others, for repeatedly re-posting this message, thus preserving it forever even if Venturis Therapeutics wanted it to quietly go away. Thanks to their diligence and hard work, I am able to copy it in below:
In the Interim Decision handed down on February 25th by the Arbitrator, Michael Zimmerman, the Arbitrator found that Montano and/or Jacobs had plagiarized Venturis’ reports, made misleading statements to investors, infringed on Venturis’ copyrights and contractually breached their agreements and duties to Venturis. Due to the delay in Venturis bringing this action, complicated by the Montano Chapter 7 Bankruptcy Filing, and the ruling as to lack of sufficient evidence of damages, Venturis was awarded only a nominal amount of attorney fees. The Arbitrator also found that Montano and Jacobs were due some amount of the back salary from Venturis that they were claiming, stemming from working at Venturis from early 2012 through the middle of 2013; however, the amount due to Montano and Jacobs is less than the outstanding legal Judgment against Montano held by affiliates of Venturis.
I'd like to also thank Venturis Therapeutics for their integrity acknowledging this undeniable fact--by trying to erase it. Nothing speaks louder than actions. Once the judge issues his exact 7-figure determination, I'm hearing the rumor that collection efforts aggressively commence. It's over, folks. Goodbye Venturis Therapeutics.
The only question in my mind is, does the company get liquidated by Dan Montano, or by a court--assuming it files for bankruptcy? There is no hope for survival because this is a company with no revenues and no products on the market. Its fate was sealed in February 2020. Actually long before that, but we'll save that for another message, or upcoming quiz question.
For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155716827
And to hear more from a Venturis insider who spilled the beans:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155941891
NEW INDICATION: I'm continuing to research Venturis Therapeutics's new potential alcoholic impotence (AI) indication. There's a lot of information I have to share. The problem for AI patients is that drunk sperm are uninterested in swimming to fertilize an egg, they just turn around and swim towards the bar. And in those few instances where fertilization actually occurs, usually the mother's body will spontaneously abort the fetus once it discovers it was created from drunk sperm.
But I have other good news as well. My research is suggesting there's yet another indication which may be viable for Venturis Therapeutics: autoalcoholism.
But sadly, it does not appear that Venturis Therapeutics's drug is going to be useful to treat alcoholic dementia. I guess the alcoholically demented are going to just stay that way until they pass away. But when an alcoholic has reached the stage of alcoholic dementia, the end is very close anyway and there's little time left.
All of this is probably moot, however, since Venturis Therapeutics is a zombie company that's about to be liquidated:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156515237
Question 8: Which of the following are bona fide clinical trial developments at Venturis Therapeutics under the leadership of Calvin Wallen III and Grant Gordon?
A) 200+ heart disease patients (CHD) were treated and had their lives saved in the Phase II clinical trial.
B) 300+ diabetic foot ulcer (DFU) patients were treated in the Phase III trial and all of their wounds were healed, resulting in Venturis Therapeutics’ first FDA approval.
C) 1 alcoholic impotence (AI) patient was treated, but apparently it didn’t work because he’s still impotent and still a belligerent drunk. ("Be fruitful and multiply...")
D) Zero patients have been treated in clinical trials since Calvin Wallen III’s hostile takeover, despite promises to Venturis/CVBT shareholders in 2013, in 2014, in 2015, in 2016, in 2017, in 2018, in 2019, in 2020…at least the record is consistent!
(The correct answer is at the bottom of this posting)
This is part of our new Venturis Therapeutics educational trivia series. Unlike our cheap imitators who lack a single original thought in their minimally-educated brains, ours is an educational and fun exercise for the whole family while we're mostly not social distancing anymore (and are now sorry we didn't).
For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155716827
The correct answer is: (D), zero patients have been treated during the brilliant tenure of Calvin Wallen III and Grant Gordon. Zero drugs have been approved. Zero clinical progress has been made. Indeed, Venturis Therapeutics has not run a single clinical trial since 2007. This is the only thing that matters for a development-stage biotechnology company which has no approved drugs on the market and no revenues. So in the last 14 years, Venturis Therapeutics has done nothing meaningful to advance its drugs towards FDA approval. This is why Wall Street considers this company a zombie company and this management team a bunch of losers (although in their defense, they've at least attracted the attention of the Guinness Book of World Records, as this is apparently the only biotech company in history run by 2 dropouts who among them only have only 1 high school diploma and no college or advanced degrees, and who consider themselves "autodidacts" (hahahaha) instead of autoalcoholics). Zzzombie….zzzombie….zzzzzombie……..zzzzzzzzzzzz……..
And here are the earlier questions in our series:
Question 1: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155716885
Question 2: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155768166
Question 3: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155830431
Question 4: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155887684
Question 5: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156041065
Question 6: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156227658
Question 7: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156355920